BEIJING, June 5, 2025 /PRNewswire/ -- Tsingke Biotech recently participated in TIDES USA 2025, the leading international event for oligonucleotide and peptide therapeutics, held in San Diego from May 19 to 22. As a repeat exhibitor, Tsingke highlighted its integrated "The Great Gene Factory" model, offering precision synthesis solutions from early discovery to large-scale manufacturing.

During the exhibition, Tsingke showcased its core offerings including:

End-to-End synthesis tools, such as the Syn-HCY Series (12P/192P/768B), delivering high-throughput oligo production for CRISPR, IVD, and research needs
GMP production system, featuring the Syn-HL12 synthesizer capable of 200 nmol to 12 mmol scale, equipped with real-time monitoring for UV, pH, and conductivity
Application coverage across ASO/siRNA therapeutics, gene editing, mRNA vaccine templates, and diagnostic probes
Over 300 chemical modifications and a robust raw material supply chain supporting batch-to-batch consistency

Visitors were particularly impressed by Tsingke's automation capabilities and flexible modular equipment designed to support high-purity, long-chain, and highly modified oligonucleotide synthesis. The company's ability to integrate reagents, instruments, and services into a unified platform drew significant attention from pharmaceutical and biotech partners.

Tsingke Biotech remains committed to empowering life sciences and therapeutic innovation by building a world-class platform for nucleic acid synthesis.

For inquiries or collaboration, please contact us at market@tsingke.com

Visit: www.tsingke.com

Photo -

View original content:https://www.prnewswire.co.uk/news-releases/tsingke-biotech-participates-in-tides-usa-2025-demonstrates-full-scale-oligonucleotide-synthesis-capabilities-302473977.html

Images

Tags

More Like This

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

Tsingke Successfully Showcases Innovations at BIO-Europe 2024

Tsingke Showcases at AACR 2025 -- Advancing Global Cancer Research with Integrated Synthesis Solutions

Tsingke Shines at Cell & Gene Therapy International 2024

Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"

2024 Tsingke High-Impact Literature Compilation - Gene Synthesis

Ex-FDA Expert Dr. Yaning Wang Joins Tsingke to Drive Small Nucleic Acid Drug Innovation

ST Pharm breaks ground on 2nd State-of-the-Art Oligonucleotide Facility